Citations

Clear

4061 citation(s) found for "Do, Elizabeth K".

Time-of-Day of Initial Immune Checkpoint Inhibitor Administration and Its Impact on Outcomes in Metastatic Non–Small Cell Lung Cancer
Schultz, Sydney , Mohr, Riley , Cole, Kristin , Knott, Amanda, Amundson, Briana K., King, Elizabeth B , Hardler, Michael , Chittavong, Vayou, Campian, Jian , Dimou, Anastasios

Mayo Clinic

JCO Oncology Practice | November 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-26-00491 | PMID 42981555 Get It

Purpose Immune checkpoint inhibitors (ICIs) are integral to first-line treatment of metastatic non–small cell lung cancer (NSCLC). Circadian biology may influence antitumor immunity, raising the hypothesis that time-of-day of ICI administration could affect outcomes. We evaluated the association between initial and cumulative ICI administration time-of-day and clinical outcomes in metastatic NSCLC. Materials and Methods We conducted a retrospective cohort study of 778 patients with metastatic NSCLC treated with first-line ICI-containing therapy across Mayo Clinic sites between January 2021 and March 2024. Patients were stratified by time-of-day of first ICI administration: early (0700-1200) versus late (1201-2400). Primary end points were overall survival (OS) and progression-free survival (PFS); the secondary end point was immune-related toxicity. Multivariable Cox proportional hazards models adjusted for clinically relevant covariates. Exploratory analyses evaluated cumulative infusion time-of-day and alternative administration-time thresholds using spline and cut-point analyses. Results Of 778 patients, 277 received early and 501 received late initial ICI administration. Median OS was 1.33 versus 1.48 versus years and median PFS was 0.65 versus 0.67 years in the late and early groups, respectively. Time-of-day of initial ICI administration was not associated with OS (HR, 1.01 [95% CI, 0.85 to 1.20]) or PFS (HR, 1.03 [95% CI, 0.88 to 1.21]). Findings were unchanged after multivariable adjustment. Immune-related toxicity occurred in 26.9% and 24.2% of patients in the late and early groups, respectively ( P = .40). Cumulative infusion time-of-day was not associated with OS or PFS, and spline analyses identified no significant administration-time threshold associated with outcomes. Conclusion In this large real-world cohort of patients with metastatic NSCLC, neither initial nor cumulative ICI administration time-of-day was associated with survival or immune-related toxicity. Prospective studies incorporating chronotype and circadian biomarkers are warranted to further define the role of chronotherapy in immuno-oncology.
Opioid prescribing and pain trajectories after periacetabular osteotomy
Guarin Perez, Sergio F , Restrepo, Diego J. , Tai, Ta-Wei , Hanson, Kristine , Habermann, Elizabeth , Sierra, Rafael J

Mayo Clinic

Bone & Joint Open | November 4, 2026 | Volume: 7 | Issue: 11 | Pages: 1410-1418

10.1302/2633-1462.711.bjo-2026-0191.r1 | PMID 42976904 Get It

Aims Periacetabular osteotomy (PAO) is performed in young, opioid-naive patients and is associated with postoperative pain. Optimizing perioperative analgesia while limiting opioid exposure remains a priority. This study evaluated postoperative pain trajectories, hospital length of stay (LOS), and opioid-prescribing patterns associated with an institutional transition from epidural-based to periarticular injection (PAI)-based analgesia after PAO. Secondary aims were to assess the influence of preoperative opioid exposure and compare outcomes between ropivacaine-based and bupivacaine PAI formulations. Methods The study included 724 patients who underwent PAO between January 2010 and December 2022 at a single academic institution, with epidural use replaced by PAI in 2016. Patients were stratified by postoperative analgesia strategy: epidural catheter (n = 333) or PAI (n = 391). Outcomes included daily postoperative pain scores, LOS, discharge opioid prescriptions (morphine milligram equivalents (MMEs)), total opioid exposure, and 30-day refill rates. Statistical comparisons were performed using chi-squared, Fisher’s exact, and Kruskal–Wallis tests. Results Baseline characteristics were similar between groups. Epidural analgesia was associated with lower pain scores during the first 48 hours (last pain postoperative day 0 to 1: mean 2.9 (SD 2.0) vs 4.7 (SD 2.1); p < 0.001), whereas the PAI group had a shorter LOS (mean 2.2 days (SD 1.0) vs 3.4 days (SD 0.9); p < 0.001) and higher pain scores at discharge (mean 4.8 (SD 1.9) vs 4.0 (SD 1.9); p < 0.001). Median discharge opioid prescriptions (313 (IQR 225 to 388) vs 825 (IQR 600 to 1,000) MMEs) and total 30-day opioid exposure (360 (IQR 275 to 575) vs 900 (IQR 638 to 1,100) MMEs) were lower in the PAI group (both p < 0.001), while refill rates were higher (34.0% vs 19.2%; p < 0.001). Within the PAI cohort, ropivacaine-based and bupivacaine injections showed similar pain trajectories and refill rates. Conclusion Epidural analgesia provided superior early postoperative pain control, whereas PAI-based pathways enabled earlier discharge and lower overall opioid prescribing but with higher refill rates. These findings highlight trade-offs in contemporary perioperative pathways and support individualized analgesic strategies after PAO. Cite this article: Bone Jt Open 2026;7(11):1410–1418.
The neuropsychological profile of an individual with early-onset CSF1R- related disorder with biallelic mutation
Wallace, Elizabeth R , Block, Cady K. , Rush, Beth K

Mayo Clinic

Neurocase | November 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-7

10.1080/13554794.2026.2757240 | PMID 42971717 Get It

Predicting Prognosis in Primary Sclerosing Cholangitis: Conventional to Functional MRI
Thompson, Cole P. , Aswani, Yashant , Carey, Elizabeth J. , Silva, Aubrienne N, Panda, Anshuman J, Venkatesh, Sudhakar K , Silva, Alvin C , Sandrasegaran, Kumar

Mayo Clinic

RadioGraphics | October 29, 2026 | Volume: 46 | Issue: 11 | Pages: No page available

10.1148/rg.260030 | PMID 42955837 Get It

MRI and MR cholangiopancreatography are central to the diagnosis, surveillance, and assessment of primary sclerosing cholangitis, while functional techniques such as MR elastography and gadoxetate-enhanced MRI provide complementary evolving biomarkers with potential prognostic value and utility for risk stratification.
Normative transcriptomic clues to thalamic developmental vulnerability in C9orf72-FTLD
So, Isis , Bouzigues, Arabella , Ferry-Bolder, Eve , Cullen, Eva , Foster, Phoebe H , Farley, Sophie , Convery, Rhian , Jiskoot, Lize C , Seelaar, Harro , Galimberti, Daniela , Vandenberghe, Rik , Laforce, Robert , Bruffaerts, Rose , Bertoux, Maxime , Lebouvier, Thibaud , Solje, Eino , Xiong, Chengjie , Thompson, Alexander , Körtvélyessy, Peter , Otto, Markus , Uzelac, Zeljko , Illán-Gala, Ignacio , Gerhard, Alexander , Ducharme, Simon , Santana, Isabel , Masellis, Mario , Rowe, James B , Graff, Caroline , Moreno, Fermin , Synofzik, Matthis , Rademakers, Rosa , Kolander, Tyler , Boeve, Brad , Rosen, Howard J , Lee, Suzee E , Rohrer, Jonathan D , Andrews, Tallulah S , Finger, Elizabeth C.

Mayo Clinic

No container title available | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.10.09.26365172 | PMID 42999299 Get It

C9orf72 encodes a protein that is important for both typical neurodevelopment and homeostatic processes across the lifespan. Pathogenic C9orf72 repeat expansions constitute the most common genetic cause of frontotemporal lobar degeneration (FTLD). Collectively, preclinical models and clinical neuroimaging studies have observed smaller thalamic volumes in C9orf72-associated FTLD, including in asymptomatic young adult C9orf72 repeat expansion carriers across 18 to 30 years old, supportive of potential neurodevelopmental origins. However, it is unknown whether asymptomatic young adult C9orf72 expansion carriers demonstrate volume differences in specific thalamic nuclei, as reported in older asymptomatic carriers and symptomatic patients; if so, normative transcriptomic patterns could reveal relevant neurodevelopmental and/or FTLD-related neurodegenerative processes. This study investigated volumetric MRI differences of the thalamic nuclei in asymptomatic young adult C9orf72 expansion carriers compared to non-carriers, and examined spatial associations with normative thalamic transcriptomics from 8 weeks post-conception through middle age. Young adult C9orf72 expansion carriers (n=72) and non-carriers (n=48) were enrolled in the Frontotemporal Dementia Prevention Initiative across Europe, Canada, and the USA (ages: 18-30 years; sex: 57% female). Spatial associations between young adult thalamic nuclei volumes and normative transcriptomics from the Allen Human Brain Atlas were examined using complementary data-driven and hypothesis-driven approaches. Spatial expression patterns of transcripts of interest were characterized across prenatal and postnatal neurodevelopment using BrainSpan data. Smaller volumes of the pulvinar, mediodorsal, and lateral nuclei were observed in young adult C9orf72 expansion carriers compared to non-carriers. These nuclei showed higher normative expression of transcripts involved concurrently in neurodevelopmental and C9orf72-associated FTLD neurodegenerative processes (including lysosomal, autophagic, and small GTPase functions), and lower normative expression of CALB1, a marker of prenatal human thalamic development. Normative expression of CALB2 (another human thalamic development marker) yielded positive correlations with C9orf72 across prenatal development to adulthood. These findings identify candidate transcripts that may provide insight into the molecular architecture leading to smaller thalamic nuclei volumes in C9orf72-associated FTLD.
The hearing healthcare workforce: insights into density, distribution and opportunities for capacity-development
Mokoh, Lilian , Law, Shen Hong , Jaffer, Ali F. , Seguya, Amina , Kahinga, Aveline Aloyce , Nakku, Doreen , Holt, Elizabeth A.L. , Dillard, Lauren K. , Zalaquett, Nader , Frost, Robert, Patterson, Rolvix H. , Nuss, Sarah , Xu, Mary Jue , Elwell, Zachary , Waterworth, Christopher J.

Mayo Clinic

International Journal of Audiology | October 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-13

10.1080/14992027.2026.2738096 | PMID 42860054 Get It

Innovations in Microsurgery: A Qualitative Appraisal of a Novel 3D-Printed Microscope
Zona, Emily E. , Eftekari, Sahand, Wu, Elizabeth P., Quach, Myiah Phuong Kim, Shaffrey, Ellen C , Carbullido, M Kristine, Zeng, Weifeng , Dingle, Aaron M

Mayo Clinic

Journal of Reconstructive Microsurgery | October 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2972-6217 | PMID 42838114 Get It

Background Microsurgery is a critical component of plastic and reconstructive surgery. However, the high cost of training and equipment pose significant barriers, particularly in resource-limited settings. To address this challenge, the Microsurgery and Regenerative Medicine Lab within the Division of Plastic Surgery at the University of Wisconsin developed a low-cost, 3D-printed surgical microscope. This study qualitatively appraised the use of this novel microscope for microsurgery training by surveying surgeons about their experiences using this tool relative to traditional magnification methods. Methods In this prospective, multi-institutional appraisal study, surgical residents, fellows, and attending surgeons with varying microsurgical experience performed a single end-to-end microsurgical anastomosis on chicken thigh femoral arteries using the 3D-printed microscope. Participants then completed a survey assessing ease of use, adequacy for microsurgical training, educational value, and perceived impact on teaching capacity in local and global settings. Results Over 80% of participants reported that performing an end-to-end anastomosis was easier or equivalent using the 3D-printed microscope compared to surgical loupes. All respondents expressed willingness to use the device for microsurgery teaching and practice. Additionally, 91.7% (33/36) believed access to the microscope would enhance microsurgical teaching at their home institutions, and 97.1% (34/35) felt it would improve teaching capacity in globally. Qualitative feedback was overwhelmingly positive, with suggestions primarily related to ergonomics and lighting. Conclusion This study supports that this low-cost, 3D-printed microscope is an effective microsurgical training tool. Ongoing design refinements informed by user feedback may further optimize its role in expanding access to microsurgery education worldwide.
“I Just Want People to See Me as a Decent Human Being”: Perceptions of Screening Mammography in an Underserved Group
Cathcart-Rake, Elizabeth , Fee-Schroeder, Kelliann C., Looney, Sandy M., Phelan, Lynn M., Herndon, Justine , Olswold, Tiffany M, Oldham, Emmett E, Fonseca, Emrys , Stephenson, Noreen

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.6004/jnccn.2026.7050 | PMID 42838084 Get It

Background: This qualitative study sought to understand factors related to low rates of screening mammography among transgender and gender-diverse (TGD) individuals and how these rates might be improved. Methods: Individuals who self-reported as TGD were recruited from multiple sites and national patient advocates. Consenting participants completed an individual interview using a semistructured guide informed by the Health Belief Model (HBM). Interview data were analyzed using thematic analysis. Results: A total of 44 individuals completed the interview (median age, 44.9 years; range, 19–77 years); 11% were a racial/ethnic minority; and 52%, 20%, and 25%, respectively, self-identified as a transgender woman, transgender man, or nonbinary. Three themes emerged around constructs in the HBM. First, individuals voiced a hope to be treated equally (“I just want to go to work, pay my taxes, love my family, and go along my day and be a good human”) and described how such equitable treatment during screening guarded against gender dysphoria and favored gender affirmation (“it is affirming…being treated as any other woman”). Second, barriers and facilitators related to mammography were identified, including the need to address cost/low cost (“screenings are a luxury”); prior negative/positive experiences (“they would call my name and look at me but dismiss me”); absence/presence of education (“none of the doctors…ever told me what that process looks like”); and perceived low/high cancer risk (“my mom died pretty young from breast cancer”). Finally, practical recommendations were offered, including individual changing/waiting rooms, hiring gender-diverse staff, and engaging clinicians who provide whole-person, trauma-informed care. Conclusions: Mammographic screening among TGD individuals could be improved by proactively creating safe, affirming spaces; working to lower costs; providing educational materials tailored to the TGD community about cancer risk and the practical aspects of screening; and hiring gender-diverse staff. These recommendations from TGD participants merit implementation as well as further study.
The Biomarker Revolution in Kidney Transplantation
Cho, Elizabeth , Lopez, Yvette Y, Alasfar, Sami

Mayo Clinic

Journal of Clinical Medicine | September 30, 2026 | Volume: 15 | Issue: 19 | Pages: 7601

10.3390/jcm15197601 | PMID 42882063 Get It

Since the first successful kidney transplant in 1954, transplant medicine has advanced significantly, achieving favorable one-year outcomes. However, despite excellent short-term outcomes, long-term renal allograft survival remains sub-optimal, with acute rejection continuing to be a major contributor to death-censored allograft loss. Current approaches for post-transplant surveillance and rejection monitoring rely on either nonspecific markers that often detect injury late in their course or invasive procedures associated with procedural risks and complications. To address these limitations, numerous non-invasive biomarkers have been introduced into solid organ transplantation research with the goal of improving allograft surveillance, facilitating earlier detection of rejection and complementing existing diagnostic approaches. Although several biomarkers have demonstrated clinical promise, none currently possess sufficient accuracy to replace kidney allograft biopsy. Biomarkers under investigation include blood-, tissue- and urine-based specimens. Their development and validation as independent markers have been limited by smaller sample size, heterogenous targets, variable performance characteristics and suboptimal sensitivity and specificity. In response, the field has increasingly shifted toward multimodal approaches that combine biomarkers and incorporate artificial intelligence to improve diagnostic accuracy and outcomes prediction. This review summarizes current biomarkers, discusses their limitations and explores future directions for biomarker development and clinical implementation.
Assessment of Fairness and Bias of an Image-based Surgical Site Infection Detection AI Model
Lee, Frank G. , Choudhary, Ashok , Li-Han, Leo Yan , Dale, Erica L., Bankes, Audrey C , Varghese, Chris , Anderson, Stephanie S., Habermann, Elizabeth B. , Etzioni, David A. , McLaughlin, Sarah A. , Salehinejad, Hojjat , Thiels, Cornelius A. , Varghese, Chris , Habermann, Elizabeth , Dale, Erica , Bankes, Audrey , Choudhary, Ashok , Lee, Frank G

Mayo Clinic

No container title available | September 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.09.22.26363636 Get It

ABSTRACT Background Evaluating fairness in artificial intelligence (AI) is essential before clinical implementation to prevent unintended harm across diverse patient populations. This study assesses performance differences of an image-based surgical site infection (SSI) detection model across age, gender, geography, race, and skin color. Methods Model development/validation study using retrospective, multicenter data across surgical subspecialties from adults who submitted an image of their incision via the electronic health record within 30 days of their procedure between 2019-2024. Area under receiver operating curve (AUROC) was compared by age (<55 vs. ≥55 years old), gender (male vs. female), geography (Rochester, Minnesota vs. Jacksonville, Florida vs. Scottsdale, Arizona vs. regional Minnesota/Wisconsin areas), race (White/Caucasian vs. non-White/Caucasian), and skin color (Fitpatrick I-III vs. IV-VI and Monk A-E vs. F-J). Results Training data contained 13,702 images from 4,274 patients between 2019-2022 (50.1% ≥55 years old; 63.2% female; 91.6% White/Caucasian; 58.5% Rochester, 17.3% Florida, 10.5% Arizona; 96.3% light skin tone), of which 1,348 images (9.8%) had an SSI. No differences in SSI detection existed for age, gender, race, or skin color (AUROC 0.83-0.87, p>0.09), however geographical differences were significant: lowest AUROC 0.83 (95% CI 0.77-0.88) vs. highest AUROC 0.87 (95% CI 0.84-0.89, p=0.01). Temporal validation using 4,242 images from 1,353 patients between 2022-2023 showed intact fairness across subgroups (ΔAUROC ≤0.06) except geography (ΔAUROC ≤0.16). Conclusions The model behaved fairly across age, gender, race, and skin color, however geographical differences persisted. These findings have practical implications underscoring the importance of evaluating bias in clinical AI before deployment.